229 related articles for article (PubMed ID: 21427395)
21. Longitudinal evaluation of three azithromycin distribution strategies for treatment of trachoma in a sub-Saharan African country, Mali.
Schémann JF; Guinot C; Traore L; Zefack G; Dembele M; Diallo I; Traore A; Vinard P; Malvy D
Acta Trop; 2007 Jan; 101(1):40-53. PubMed ID: 17239332
[TBL] [Abstract][Full Text] [Related]
22. Reduction and return of infectious trachoma in severely affected communities in Ethiopia.
Lakew T; House J; Hong KC; Yi E; Alemayehu W; Melese M; Zhou Z; Ray K; Chin S; Romero E; Keenan J; Whitcher JP; Gaynor BD; Lietman TM
PLoS Negl Trop Dis; 2009; 3(2):e376. PubMed ID: 19190781
[TBL] [Abstract][Full Text] [Related]
23. A rationale for continuing mass antibiotic distributions for trachoma.
Ray KJ; Porco TC; Hong KC; Lee DC; Alemayehu W; Melese M; Lakew T; Yi E; House J; Chidambaram JD; Whitcher JP; Gaynor BD; Lietman TM
BMC Infect Dis; 2007 Aug; 7():91. PubMed ID: 17683646
[TBL] [Abstract][Full Text] [Related]
24. Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia.
Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Gessese D; Ayenew G; Melak B; Chanyalew M; Tadesse Z; Callahan EK; Nash SD
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006270. PubMed ID: 29451881
[TBL] [Abstract][Full Text] [Related]
25. The efficacy of oral azithromycin in clearing ocular chlamydia: mathematical modeling from a community-randomized trachoma trial.
Liu F; Porco TC; Mkocha HA; Muñoz B; Ray KJ; Bailey RL; Lietman TM; West SK
Epidemics; 2014 Mar; 6():10-7. PubMed ID: 24593917
[TBL] [Abstract][Full Text] [Related]
26. Mass distribution of azithromycin for trachoma control is associated with increased risk of azithromycin-resistant Streptococcus pneumoniae carriage in young children 6 months after treatment.
Coles CL; Mabula K; Seidman JC; Levens J; Mkocha H; Munoz B; Mfinanga SG; West S
Clin Infect Dis; 2013 Jun; 56(11):1519-26. PubMed ID: 23487375
[TBL] [Abstract][Full Text] [Related]
27. Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children.
Whitty CJ; Glasgow KW; Sadiq ST; Mabey DC; Bailey R
Pediatr Infect Dis J; 1999 Nov; 18(11):955-8. PubMed ID: 10571428
[TBL] [Abstract][Full Text] [Related]
28. Randomised controlled trial of single-dose azithromycin in treatment of trachoma.
Bailey RL; Arullendran P; Whittle HC; Mabey DC
Lancet; 1993 Aug; 342(8869):453-6. PubMed ID: 8102427
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions.
Keenan JD; See CW; Moncada J; Ayele B; Gebre T; Stoller NE; McCulloch CE; Porco TC; Gaynor BD; Emerson PM; Schachter J; Lietman TM
Invest Ophthalmol Vis Sci; 2012 Jan; 53(1):235-40. PubMed ID: 22159017
[TBL] [Abstract][Full Text] [Related]
30. Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma.
Keenan JD; Ayele B; Gebre T; Moncada J; Stoller NE; Zhou Z; Porco TC; McCulloch CE; Gaynor BD; Emerson PM; Schachter J; Lietman TM
Clin Infect Dis; 2012 Jan; 54(2):253-6. PubMed ID: 22095569
[TBL] [Abstract][Full Text] [Related]
31. Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial.
Amza A; Kadri B; Nassirou B; Stoller NE; Yu SN; Zhou Z; Chin S; West SK; Bailey RL; Mabey DC; Keenan JD; Porco TC; Lietman TM; Gaynor BD;
PLoS Negl Trop Dis; 2012; 6(4):e1586. PubMed ID: 22545165
[TBL] [Abstract][Full Text] [Related]
32. Mass treatment with single-dose azithromycin for trachoma.
Solomon AW; Holland MJ; Alexander ND; Massae PA; Aguirre A; Natividad-Sancho A; Molina S; Safari S; Shao JF; Courtright P; Peeling RW; West SK; Bailey RL; Foster A; Mabey DC
N Engl J Med; 2004 Nov; 351(19):1962-71. PubMed ID: 15525721
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for ocular infection with Chlamydia trachomatis in children 6 months following mass treatment in Tanzania.
Cajas-Monson LC; Mkocha H; Muñoz B; Quinn TC; Gaydos CA; West SK
PLoS Negl Trop Dis; 2011 Mar; 5(3):e978. PubMed ID: 21423645
[TBL] [Abstract][Full Text] [Related]
34. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial.
Keenan JD; Arzika AM; Maliki R; Elh Adamou S; Ibrahim F; Kiemago M; Galo NF; Lebas E; Cook C; Vanderschelden B; Bailey RL; West SK; Porco TC; Lietman TM;
Lancet Glob Health; 2020 Feb; 8(2):e288-e295. PubMed ID: 31981558
[TBL] [Abstract][Full Text] [Related]
35. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.
Chidambaram JD; Alemayehu W; Melese M; Lakew T; Yi E; House J; Cevallos V; Zhou Z; Maxey K; Lee DC; Shapiro BL; Srinivasan M; Porco T; Whitcher JP; Gaynor BD; Lietman TM
JAMA; 2006 Mar; 295(10):1142-6. PubMed ID: 16522834
[TBL] [Abstract][Full Text] [Related]
36. Population coverage and factors associated with participation following a mass drug administration of azithromycin for trachoma elimination in Amhara, Ethiopia.
Ebert CD; Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Gessese D; Ayenew G; Ayele Z; Melak B; Chanyalew M; Gashaw B; Tadesse Z; Callahan EK; Jenness SM; Nash SD
Trop Med Int Health; 2019 Apr; 24(4):493-501. PubMed ID: 30674087
[TBL] [Abstract][Full Text] [Related]
37. Mass treatment with azithromycin for trachoma control: participation clusters in households.
Ssemanda EN; Munoz B; Harding-Esch EM; Edwards T; Mkocha H; Bailey RL; Sillah A; Stare D; Mabey DC; West SK;
PLoS Negl Trop Dis; 2010 Oct; 4(10):. PubMed ID: 20957196
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities.
Wilson N; Goodhew B; Mkocha H; Joseph K; Bandea C; Black C; Igietseme J; Munoz B; West SK; Lammie P; Kasubi M; Martin DL
Ophthalmic Epidemiol; 2019 Feb; 26(1):1-6. PubMed ID: 30543311
[TBL] [Abstract][Full Text] [Related]
39. Latrine promotion for trachoma: assessment of mortality from a cluster-randomized trial in Ethiopia.
Gebre T; Ayele B; Zerihun M; House JI; Stoller NE; Zhou Z; Ray KJ; Gaynor BD; Porco TC; Emerson PM; Lietman TM; Keenan JD
Am J Trop Med Hyg; 2011 Sep; 85(3):518-23. PubMed ID: 21896815
[TBL] [Abstract][Full Text] [Related]
40. Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia.
Stare D; Harding-Esch E; Munoz B; Bailey R; Mabey D; Holland M; Gaydos C; West S
Ophthalmic Epidemiol; 2011 Feb; 18(1):20-9. PubMed ID: 21275593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
